Average Co-Inventor Count = 7.43
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astex Therapeutics Limited (11 from 123 patents)
2. Cancer Research Technology Limited (1 from 262 patents)
3. The Institute of Cancer Research: Royal Cancer Hospital (1 from 51 patents)
11 patents:
1. 9051278 - 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
2. 8779147 - 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
3. 8778936 - Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
4. 8293767 - 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
5. 8110573 - Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
6. 8080666 - 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
7. 8013163 - 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
8. 7977477 - Benzimidazole derivatives and their use as protein kinase inhibitors
9. 7825140 - 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
10. 7745638 - 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
11. 7385059 - 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators